E.I.D. Parry (India) Ltd.
EIDPARRY · NSE · Basic Materials
With a 20% margin of safety, our buy-below price is ₹3,575.28. Low-confidence estimate — limited data.
Piotroski F-score 5/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%9.9%
- ✓Low debt (D/E < 0.5)0.24x
- ✕Positive free cash flow
- ✓Revenue growth > 10%16%
- –Earnings growing
- ✕Net margin ≥ 10%1.5%
- ✕Current ratio > 1.51.42
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✕Altman Z in safe zoneZ 2.81
- ✕Piotroski ≥ 75/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
Weaknesses
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Revenue growing (16% YoY).
- •Trading in our value buy zone versus sector peers.
- •Well off its 52-week high — possible mean-reversion.
- •Trades ~516% below our estimated fair value.
About E.I.D. Parry (India) Ltd.
E.I.D.- Parry (India) Limited, together with its subsidiaries, engages in the manufacture and sale of sugar, nutraceuticals, and distillery products in India, North America, Europe, and internationally. The company offers sugar for use in food, bakery, confectioneries, beverage, and pharmaceutical industries; and grains, such as millets and dhals, as well as rice. It also provides nutraceuticals products, such as organic spirulina and chlorella, carotenoid, astaxanthin, and l
More in Fast Moving Consumer Goods
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.